Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Margin

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) -2.7112.9514.1218.0952.12

What is the latest Core EBITDA Margin ratio of LYKA LABS ?

The latest Core EBITDA Margin ratio of LYKA LABS is -2.71 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar2026-2.71
Mar202512.95
Mar202414.12
Mar202318.09
Mar202252.12

How is Core EBITDA Margin of LYKA LABS Trending?

Years Core EBITDA Margin % Change
Mar2026 -2.71
Negative
Mar2025 12.95
-8.29
Mar2024 14.12
-21.95
Mar2023 18.09
-65.29
Mar2022 52.12 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Margin ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹298.7 Cr 2.5% 23.1% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

2.5%

23.1%

-15.3%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses